Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Lung & Bronchus (Late Stage^), 2016-2020

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Percentlate
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late ascending
US (SEER+NPCR) 1 35.3 (35.2, 35.4) N/A 141,093 65.5
Hawaii 3 30.5 (29.4, 31.6) 40 (37, 42) 595 72.9
Louisiana 3 44.2 (43.4, 45.0) 8 (6, 9) 2,548 72.2
Iowa 3 43.0 (42.1, 43.9) 9 (7, 11) 1,784 70.9
Georgia 3 40.5 (39.9, 41.0) 12 (12, 16) 4,856 70.5
Kentucky 3 58.9 (58.0, 59.8) 1 (1, 1) 3,409 69.9
Utah 3 17.2 (16.5, 17.9) 49 (49, 49) 483 69.7
West Virginia 6 52.5 (51.3, 53.8) 2 (2, 2) 1,419 69.1
Mississippi 6 47.9 (46.9, 48.9) 3 (3, 5) 1,798 68.6
Idaho 3 31.5 (30.4, 32.6) 38 (34, 41) 669 68.5
North Carolina 6 42.6 (42.1, 43.1) 11 (9, 11) 5,660 68.0
Wisconsin 6 38.7 (38.1, 39.3) 19 (15, 22) 2,999 68.0
Michigan 6 40.3 (39.8, 40.8) 13 (12, 16) 5,430 67.9
North Dakota 6 38.0 (36.2, 39.9) 21 (12, 27) 340 67.6
Alaska 6 35.0 (33.0, 37.2) 29 (21, 36) 254 67.5
California 3 25.2 (25.0, 25.4) 45 (43, 46) 11,228 67.4
Maine 6 46.5 (45.1, 47.9) 4 (3, 7) 971 67.1
South Dakota 6 37.3 (35.7, 39.0) 22 (15, 30) 421 66.9
Kansas 6 34.9 (34.1, 35.8) 31 (25, 32) 1,264 66.8
Illinois 3 39.3 (38.9, 39.8) 17 (14, 20) 6,202 66.6
Ohio 6 42.8 (42.3, 43.3) 10 (9, 11) 6,659 66.2
Pennsylvania 6 39.2 (38.8, 39.6) 18 (15, 20) 7,062 65.7
Virginia 6 34.0 (33.5, 34.5) 32 (30, 34) 3,581 65.7
Vermont 6 37.1 (35.3, 39.0) 23 (15, 31) 339 65.6
New Hampshire 6 39.6 (38.3, 40.9) 16 (12, 22) 766 65.5
South Carolina 6 38.2 (37.5, 38.9) 20 (17, 24) 2,662 65.4
Missouri 6 44.4 (43.7, 45.0) 7 (6, 9) 3,598 65.3
New Jersey 3 33.4 (32.9, 33.9) 33 (31, 36) 3,813 65.2
Delaware 6 37.1 (35.6, 38.6) 25 (17, 30) 516 65.1
Arkansas 6 46.4 (45.4, 47.3) 5 (3, 6) 1,837 65.0
Washington 5 31.8 (31.3, 32.3) 37 (35, 39) 2,893 64.9
Tennessee 6 45.0 (44.3, 45.6) 6 (5, 8) 3,952 64.8
Texas 3 29.5 (29.2, 29.8) 42 (40, 42) 8,670 64.4
Connecticut 3 35.3 (34.5, 36.0) 27 (25, 31) 1,715 64.2
Florida 6 35.0 (34.7, 35.2) 30 (27, 31) 11,275 63.8
Oklahoma 6 40.2 (39.4, 41.0) 14 (12, 18) 1,963 63.8
Montana 6 30.1 (28.8, 31.4) 41 (37, 42) 455 63.6
New York 3 35.2 (34.9, 35.5) 28 (26, 31) 8,865 63.6
Maryland 6 32.7 (32.1, 33.3) 35 (33, 37) 2,454 63.5
Wyoming 6 25.6 (23.9, 27.3) 44 (43, 47) 192 63.5
Colorado 6 23.8 (23.3, 24.4) 47 (45, 47) 1,522 63.0
Oregon 6 30.7 (30.0, 31.4) 39 (37, 41) 1,716 62.7
Nebraska 6 32.7 (31.6, 33.7) 36 (32, 39) 771 62.3
Rhode Island 6 39.8 (38.3, 41.4) 15 (12, 22) 566 62.2
Alabama 6 37.1 (36.4, 37.8) 24 (20, 26) 2,421 62.0
Minnesota 6 33.1 (32.5, 33.7) 34 (32, 37) 2,329 60.8
Massachusetts 3 36.0 (35.4, 36.5) 26 (23, 29) 3,215 60.7
New Mexico 3 20.3 (19.5, 21.0) 48 (48, 48) 566 60.5
District of Columbia 6 25.9 (24.2, 27.7) 43 (43, 47) 178 60.3
Arizona 6 24.6 (24.2, 25.1) 46 (44, 47) 2,355 59.2
Puerto Rico 6 7.7 (7.3, 8.0) N/A 339 50.1
Indiana 6
data not available
N/A
data not available
data not available
Nevada 6
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 03/03/2024 3:04 pm.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana, Nevada

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top